| Date Filed | Type | Description |
| 07/07/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 935,850 shares
@ $5, valued at
$4.7M
|
|
| 07/06/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 1,000,000 shares
@ $5, valued at
$5M
|
|
| 07/03/2023 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 1,000,000 shares
@ $5, valued at
$5M
|
|
| 06/29/2023 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Bought 1,740,000 shares
@ $5.4914, valued at
$9.6M
|
|
| 06/28/2023 |
4
| Epstein David M. (SEE REMARKS) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Sold 25,000 shares
@ $6.7, valued at
$167.5k
|
|
| 06/16/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 5,655 shares
@ $2.1, valued at
$11.9k
|
|
| 06/16/2023 |
4
| DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 5,119 shares
@ $2.1, valued at
$10.7k
|
|
| 06/16/2023 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 8,929 shares
@ $2.1, valued at
$18.8k
|
|
| 05/17/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| Mayweg Alexander (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| Shah Rajeev M. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| Menzel Garry E (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| Kulkarni Samarth (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 05/17/2023 |
4
| Dhingra Kapil (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.82, valued at
$30k
|
|
| 03/20/2023 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 7,111 shares
@ $1.67, valued at
$11.9k
|
|
| 03/20/2023 |
4
| DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 6,437 shares
@ $1.67, valued at
$10.7k
|
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| Behbahani Ali (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 4,532 shares
@ $2.62, valued at
$11.9k
|
|
| 09/19/2022 |
4
| DIXON WENDY L (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 4,103 shares
@ $2.62, valued at
$10.7k
|
|
| 09/19/2022 |
4
| Velleca Mark A. (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 4,294 shares
@ $2.62, valued at
$11.3k
|
|
| 09/19/2022 |
4
| INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Granted 6,584 shares
@ $2.62, valued at
$17.3k
|
|
| 06/30/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|